Siren Biotechnology
San Francisco, CA
Siren Biotechnology blends two revolutionary therapeutic technologies into one for a novel approach to treating cancer.AAV gene therapy and cytokine immunotherapy are two revolutionary treatment approaches that Siren Biotechnology has combined into a single, redesigned modality. This approach overcomes significant obstacles and entirely transforms how tumor cells are eliminated and anti-tumor immunity is stimulated.
sirenbiotechnology.comCompany Details
Founded
- 2020
Employees
- Between 5 - 20 employees
Raised
- $23,611,194
Headquarters Location
- San Francisco, CA
Public
- No
Acquired
- No
CEO
Nicole Paulk
Founders
- Nicole Paulk
Company Collections
These are collections Siren Biotechnology is a part of. Click on the collection name to view similar companies.
Siren Biotechnology's Investors
Siren Biotechnology's Industries
Siren Biotechnology Headquarters Location
San Francisco, CA 94158
Total Amount Raised: $23,611,194
Siren Biotechnology's Investors
Siren Biotechnology Funding Rounds
Seed
$19,611,194
Seed Investors
NZVCGrant
$4,000,000
Grant Investors
California Institute for Regenerative Medicine
Funding info provided by Diffbot.
Siren Biotechnology Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Siren Biotechnology.